In 2020，the COVID-19 epidemic broke out. In response to the changing process of global epidemic，some countries have made the development of the coronavirus vaccine to the development of the biomedical industry. The biomedicine industry is one of the seven strategic emerging industries in my country. Even because of the shortness of the day and the development of the world，it has a gap between the world，but its development is still attached. Therefore，when studying the development of Beijing’s biomedical industry，this study compares the development models of global advanced biomedical companies，analyzes the development models and current status of domestic industrial clusters，and points out the development of Beijing’s biomedical industry by comparing various industry indicators of the biomedical industry. It proposes the advantages and opportunities of Beijing’s development of the biomedical industry，and put forward policy recommendations，such as，exploring new research and development methods，strengthening the Beijing-Tianjin-Hebei regional collaboration capacity，introducing high-end team talents，improving the drug approval system and so on.